我要投票 广誉远龟龄集在保健酒行业中的票数:184
· 外 推 电 报 ·
2025-02-23 18:29:55 星期日

【广誉远龟龄集是哪个国家的品牌?】

广誉远龟龄集是什么牌子?「广誉远龟龄集」是 山西广誉远国药有限公司 旗下著名品牌。该品牌发源于山西,由创始人张斌在1998-02-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力广誉远龟龄集品牌出海!通过在本页面挂载广誉远龟龄集品牌的产品链接和联系邮箱,可以提高广誉远龟龄集产品曝光!跨境电商爆单神器,目前只要100元/年哦~

广誉远始创于明嘉靖二十年(公元1541年),距今已有473年的历史,其间历经广盛号药店、广升聚、广升蔚、广升誉、广升远、山西中药厂、山西广誉远等十几个商号药厂更迭。在清代曾与广州陈李济(1600年创建)、北京同仁堂(1669年创建)、杭州胡庆余堂(1874年创建)并称为“四大药店”,现为山西省中药企业典范,并在2006年成为首批被中华人民共和国商务部认定的“中华老字号”企业。

广誉远主导产品“龟龄集”和“定坤丹”,是中华中医药宝库珍藏的养生至宝,是博大精深的中医药文化的智慧结晶,现为国家级保密处方,分别在2008年和2011年被中华人民共和国国务院评为国家级非物质文化遗产。龟龄集、定坤丹,“御用圣品”的宫廷出身,数百年的药用历史,深刻佐证了其功效卓著;多位皇帝的相关御批,真实确凿的史料档案,更显其品味尊贵。包括龟龄集、定坤丹在内,广誉远系列产品荣获众多国际级奖项、国家级荣誉,在国际传统医药界有深远影响。

广誉远拥有丰富的产品服务群,有丸剂、胶囊剂、酒剂、片剂、颗粒剂、散剂、口服液、煎膏剂共八个剂型,继承着龟龄集、定坤丹、安宫牛黄丸、牛黄清心丸、六味地黄丸、乌鸡白凤丸等103种中药古方及炮制工艺,从方剂、配伍、选材、炮制等诸多方面,承载并展现着中华中医药文化的核心精神与巨大价值。

“尊德贵生,传承创新”是广誉远的企业理念,广誉远坚定地以文化为先导,专注于中医药领域,坚持“继承与创新”的发展策略,充分利用企业内部的产品资源,通过持续的品牌建设和创新营销,走出“特色”道路,努力打造“人无我有,人有我优,做中国最具特色的国药”之企业形象,并在未来五年内,推出精品中药“百家千店”工程,在全国范围内建立100家国医馆、1000家国药堂,包括人参、鹿茸、枸杞、西红花、地黄、肉苁蓉、参等九大GAP养植基地。

473年来,广誉远严苛制药,精益求精,秉承“修合虽无人见,存心自有天知”的古训,遵循“非义而为,一介不取;合情之道,九百何辞”的准则,恪守诚信自律的晋商精神,以信誉为根本,“以义制利”铸就了百年老店的历久弥新。

2003年,由全国著名的大型现代化医药企业——西安东盛集团投资控股,结合现代管理运营理念,将广誉远传统老店,发展成为集中成药研发、生产、销售于一体的高科技现代化制药企业。在国家“十二五规划”对中医药行业的明确指导下,在祖国全面建设小康社会的新时期,在中华民族伟大复兴的历史时刻,广誉远以精品养生中药回馈社会大众,开创智慧养生的新纪元。广誉远作为中国非物质文化遗产的传承者,将为振兴传统中医药文化,贡献应尽的社会责任与历史使命,树立起中医药文化的全新价值。

英文翻译:Guangyuyuan was founded in the 20th year of Jiajing, Ming Dynasty (1541 A.D.), which has a history of 473 years. During this period, guangyuyuan has experienced the change of more than ten famous pharmaceutical companies, such as Guangsheng drugstore, guangshengju, guangshengwei, guangshengyu, guangshengyuan, Shanxi Traditional Chinese medicine factory and Shanxi guangyuyuan. In the Qing Dynasty, it was named as "four drugstores" together with Chen Liji in Guangzhou (founded in 1600), Tongrentang in Beijing (founded in 1669) and Hu qingyutang in Hangzhou (founded in 1874). It is now a model of traditional Chinese medicine enterprises in Shanxi Province, and became one of the first batch of "old Chinese brand" enterprises recognized by the Ministry of Commerce of the people's Republic of China in 2006. Guangyuyuan's leading products "Guilingji" and "dingkundan" are the treasure of health preservation in the treasure house of traditional Chinese medicine, and the wisdom crystallization of extensive and profound traditional Chinese medicine culture. They are now state-level secret prescriptions, and were rated as national intangible cultural heritage by the State Council of the people's Republic of China in 2008 and 2011 respectively. Guilingji, dingkundan, the Royal origin of "imperial holy product", and hundreds of years of medicinal history, have proved its remarkable efficacy; the relevant imperial approvals of several emperors, authentic historical data files, show its taste and dignity. Including Guilingji and dingkundan, guangyuyuan series products have won many international and national awards, and have a profound influence in the international traditional medicine industry. Guangyuyuan has a wealth of product service groups, including eight dosage forms of pills, capsules, liquors, tablets, granules, powders, oral liquids and decoctions. It inherits 103 traditional Chinese medicine prescriptions and processing technologies, including Guilingji, dingkundan, Angongniuhuang, Niuhuang Qingxin, Liuwei Dihuang, Wuji Baifeng, etc., and carries and manufactures from many aspects, such as prescriptions, compatibility, material selection and processing It shows the core spirit and great value of Chinese traditional medicine culture. "Respecting morality, valuing health, inheriting innovation" is guangyuyuan ' In the next five years, we will launch the project of "one hundred thousand stores" of high-quality traditional Chinese medicine, and set up 100 national medicine halls and 1000 national medicine halls nationwide, including nine GAP cultivation bases including ginseng, antler, Lycium, crocus, rehmannia, Cistanche deserticola and ginseng. In the past 473 years, guangyuyuan has been strict in pharmaceutical industry, striving for perfection, adhering to the ancient motto of "no one can see the mending, no one can take it; the way to be reasonable, nine hundred words", abiding by the spirit of integrity and self-discipline of Shanxi merchants, taking reputation as the foundation, and "making profits by righteousness" has made the century old shop new for a long time. In 2003, Xi'an Dongsheng Group, a famous modern pharmaceutical enterprise in China, invested and held the shares, combined with the modern management and operation concept, and developed guangyuyuan traditional old store into a high-tech modern pharmaceutical enterprise integrating the research and development, production and sales of patent medicine. Under the clear guidance of the 12th Five Year Plan for the industry of traditional Chinese medicine, in the new era of building a well-off society in an all-round way in the motherland, and at the historical moment of the great rejuvenation of the Chinese nation, it is well-known for giving back to the public with high-quality health care traditional Chinese medicine and creating a new era of intelligent health care. Guangyuyuan, as the inheritor of Chinese intangible cultural heritage, will contribute to the revitalization of traditional Chinese medicine culture, social responsibility and historical mission, and establish a new value of Chinese medicine culture.

本文链接: https://www.waitui.com/brand/90f4e668b.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

30分钟前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

30分钟前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

30分钟前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

30分钟前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

30分钟前

本页详细列出关于鸿茅药酒的品牌信息,含品牌所属公司介绍,鸿茅药酒所处行业的品牌地位及优势。
咨询